Steve Kleinman
Impact in
- Biochemistry top 1%
- Blood transfusion and management
- Hematology top 2%
- Blood groups and transfusion
Papers in
- Hematology 18
- Blood groups and transfusion 13
- Genetics 12
- Hemoglobinopathies and Related Disorders 12
- Co-authors
- Michael P. Busch (30 shared papers)Mars Stone (15 shared papers)Darrell J. Triulzi (11 shared papers)Tamir Kanias (11 shared papers)Grier P. Page (11 shared papers)Nareg H. Roubinian (12 shared papers)Donald Brambilla (9 shared papers)Marion C. Lanteri (7 shared papers)
- Journals
- Transfusion (28 papers)Transfusion Medicine Reviews (3 papers)Emerging infectious diseases (2 papers)JCI Insight (2 papers)JAMA (1 paper)
- Partner nations
- United StatesCanadaNetherlands
In The Last Decade
Steve Kleinman
46 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 99
- Biochemistry 513
- Hematology 472
- Management of Technology and Innovation 286
- Genetics 337
- Critical Care and Intensive Care Medicine 154
Countries citing papers authored by Steve Kleinman
This map shows the geographic impact of Steve Kleinman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steve Kleinman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steve Kleinman more than expected).
Fields of papers citing papers by Steve Kleinman
This network shows the impact of papers produced by Steve Kleinman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steve Kleinman. The network helps show where Steve Kleinman may publish in the future.
Co-authors
The 25 scholars most cited alongside Steve Kleinman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 154 | |
| 2 | 2019 | 112 | |
| 3 | 2015 | 107 | |
| 4 | 2016 | 103 | |
| 5 | 2018 | 87 | |
| 6 | 2018 | 65 | |
| 7 | 2020 | 58 | |
| 8 | 2021 | 57 | |
| 9 | 2021 | 47 | |
| 10 | 2001 | 47 | |
| 11 | 2020 | 42 | |
| 12 | 2018 | 40 | |
| 13 | 2018 | 39 | |
| 14 | 2018 | 38 | |
| 15 | 2022 | 35 | |
| 16 | 2009 | 34 | |
| 17 | 2019 | 32 | |
| 18 | 2010 | 31 | |
| 19 | 2020 | 30 | |
| 20 | 2015 | 30 |
About Steve Kleinman
Steve Kleinman is a scholar working on Hematology, Genetics, Biochemistry, Infectious Diseases and Epidemiology, having authored 47 papers that have together received 1.5k indexed citations. Recurring topics across this work include Blood groups and transfusion (13 papers), Hemoglobinopathies and Related Disorders (12 papers), Blood transfusion and management (12 papers), Blood donation and transfusion practices (11 papers), Erythrocyte Function and Pathophysiology (8 papers), Hepatitis B Virus Studies (5 papers), Hepatitis C virus research (5 papers) and Liver Disease Diagnosis and Treatment (5 papers). The work is most often cited by research in Biochemistry (513 citations), Hematology (472 citations), Management of Technology and Innovation (286 citations), Genetics (337 citations) and Critical Care and Intensive Care Medicine (154 citations). Steve Kleinman has collaborated with scholars based in United States, Canada and Netherlands. Frequent co-authors include Michael P. Busch, Mars Stone, Darrell J. Triulzi, Tamir Kanias, Grier P. Page, Nareg H. Roubinian, Donald Brambilla, Marion C. Lanteri, Mark T. Gladwin and Ritchard G. Cable. Their work appears in journals such as Transfusion, Transfusion Medicine Reviews, Emerging infectious diseases, JCI Insight and JAMA.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.